Approval of esketamine for treatment-resistant depression – Author's reply

Erick H. Turner

doi:10.1016/S2215-0366(20)30044-4

Approval of esketamine for treatment-resistant depression – Author's reply

Erick H. Turner

Psychiatry

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	236
Number of pages	1
Journal	The Lancet Psychiatry
Volume	7
Issue number	3
DOIs	https://doi.org/10.1016/S2215-0366(20)30044-4
State	Published - Mar 2020

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

Access to Document

10.1016/S2215-0366(20)30044-4

Cite this

@article{146c5481a69e4c18982885a174863dc7,

title = "Approval of esketamine for treatment-resistant depression – Author's reply",

author = "Turner, {Erick H.}",

year = "2020",

month = mar,

doi = "10.1016/S2215-0366(20)30044-4",

language = "English (US)",

volume = "7",

pages = "236",

journal = "The Lancet Psychiatry",

issn = "2215-0366",

publisher = "Elsevier Limited",

number = "3",

}

TY - JOUR

T1 - Approval of esketamine for treatment-resistant depression – Author's reply

AU - Turner, Erick H.

PY - 2020/3

Y1 - 2020/3

UR - http://www.scopus.com/inward/record.url?scp=85079532483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079532483&partnerID=8YFLogxK

U2 - 10.1016/S2215-0366(20)30044-4

DO - 10.1016/S2215-0366(20)30044-4

M3 - Letter

C2 - 32087803

AN - SCOPUS:85079532483

SN - 2215-0366

VL - 7

SP - 236

JO - The Lancet Psychiatry

JF - The Lancet Psychiatry

IS - 3

ER -

Approval of esketamine for treatment-resistant depression – Author's reply

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this